These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28395809)

  • 1. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN.
    Guo D; Liu H; Gao G; Liu Y; Zhuang Y; Yang F; Wang K; Zhou T; Qin D; Hong L; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():67-69. PubMed ID: 28395809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of non-integrated induced pluripotent stem cells from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome.
    Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():70-72. PubMed ID: 28395810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome.
    Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():64-66. PubMed ID: 28395808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
    Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
    Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Isogenic Human Cell-Based System for MEN1 Syndrome Generated by CRISPR/Cas9 Genome Editing.
    Klementieva N; Goliusova D; Krupinova J; Yanvarev V; Panova A; Mokrysheva N; Kiselev SL
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.
    Bara AM; Messana A; Herring A; Hazelbaker DZ; Eggan K; Barrett LE
    Stem Cell Res; 2016 Sep; 17(2):441-443. PubMed ID: 27879221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.
    Pires C; Schmid B; Petræus C; Poon A; Nimsanor N; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Hyttel P; Freude KK
    Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-20.
    Shetty DK; Inamdar MS
    Stem Cell Res; 2016 Mar; 16(2):207-9. PubMed ID: 27345969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a TLE1 homozygous knockout human embryonic stem cell line using CRISPR-Cas9.
    Herring A; Messana A; Bara AM; Hazelbaker DZ; Eggan K; Barrett LE
    Stem Cell Res; 2016 Sep; 17(2):430-432. PubMed ID: 27879218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-39.
    Shetty DK; Inamdar MS
    Stem Cell Res; 2016 Mar; 16(2):308-10. PubMed ID: 27345991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
    Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
    Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Seo HH; Han HW; Kim JH
    Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.
    Xu P; Tong Y; Liu XZ; Wang TT; Cheng L; Wang BY; Lv X; Huang Y; Liu DP
    Sci Rep; 2015 Jul; 5():12065. PubMed ID: 26156589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing.
    Angsutararux P; Luanpitpong S; Chingsuwanrote P; Supraditaporn K; Waeteekul S; Terbto P; Lorthongpanich C; Laowtammathron C; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2019 Dec; 41():101618. PubMed ID: 31677524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human iPSCs from urine derived cells of a non-affected control subject.
    Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
    Stem Cell Res; 2017 Jan; 18():33-36. PubMed ID: 28395799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a gene-corrected isogenic control hiPSC line derived from a familial Alzheimer's disease patient carrying a L150P mutation in presenilin 1.
    Poon A; Schmid B; Pires C; Nielsen TT; Hjermind LE; Nielsen JE; Holst B; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):466-469. PubMed ID: 27789395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of MUi009 - A human induced pluripotent stem cells from a 32year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2.
    Wongkummool W; Maneepitasut W; Tong-Ngam P; Tangprasittipap A; Munkongdee T; Boonchuay C; Svasti S; Kitiyanant N; Paiboonsukwong K; Fucharoen S; Tubsuwan A
    Stem Cell Res; 2017 Apr; 20():80-83. PubMed ID: 28395745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an Abcc8 heterozygous mutation human embryonic stem cell line using CRISPR/Cas9.
    Guo D; Liu H; Gao G; Ruzi A; Wang K; Wu H; Lai K; Liu Y; Yang F; Lai L; Li YX
    Stem Cell Res; 2016 Nov; 17(3):670-672. PubMed ID: 27934605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene.
    Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
    Stem Cell Res; 2016 Sep; 17(2):273-276. PubMed ID: 27879211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene.
    Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
    Stem Cell Res; 2016 Sep; 17(2):292-295. PubMed ID: 27879214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.